Watson PH - Search Results

1

Potential role of estrogen receptor alpha (ERalpha) phosphorylated at Serine118 in human breast cancer in vivo.

Murphy LC, Weitsman GE, Skliris GP, Teh EM, Li L, Peng B, Davie JR, Ung K, Niu YL, Troup S, Tomes L, Watson PH. Murphy LC, et al. Among authors: watson ph. J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):139-46. doi: 10.1016/j.jsbmb.2006.09.021. Epub 2006 Nov 7. J Steroid Biochem Mol Biol. 2006. PMID: 17092701 Review.

2

S100A7 and the progression of breast cancer.

Emberley ED, Murphy LC, Watson PH. Emberley ED, et al. Among authors: watson ph. Breast Cancer Res. 2004;6(4):153-9. doi: 10.1186/bcr816. Epub 2004 Jun 4. Breast Cancer Res. 2004. PMID: 15217486 Free PMC article. Review.

3

Is oestrogen receptor-beta a predictor of endocrine therapy responsiveness in human breast cancer?

Murphy LC, Watson PH. Murphy LC, et al. Among authors: watson ph. Endocr Relat Cancer. 2006 Jun;13(2):327-34. doi: 10.1677/erc.1.01141. Endocr Relat Cancer. 2006. PMID: 16728566 Review.

4

Estrogen receptor-beta regulates psoriasin (S100A7) in human breast cancer.

Skliris GP, Lewis A, Emberley E, Peng B, Weebadda WK, Kemp A, Davie JR, Shiu RP, Watson PH, Murphy LC. Skliris GP, et al. Among authors: watson ph. Breast Cancer Res Treat. 2007 Jul;104(1):75-85. doi: 10.1007/s10549-006-9390-x. Epub 2006 Sep 29. Breast Cancer Res Treat. 2007. PMID: 17009105

5

Estrogen receptor-alpha phosphorylated at Ser118 is present at the promoters of estrogen-regulated genes and is not altered due to HER-2 overexpression.

Weitsman GE, Li L, Skliris GP, Davie JR, Ung K, Niu Y, Curtis-Snell L, Tomes L, Watson PH, Murphy LC. Weitsman GE, et al. Among authors: watson ph. Cancer Res. 2006 Oct 15;66(20):10162-70. doi: 10.1158/0008-5472.CAN-05-4111. Cancer Res. 2006. PMID: 17047081

6

Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target.

Skliris GP, Leygue E, Watson PH, Murphy LC. Skliris GP, et al. Among authors: watson ph. J Steroid Biochem Mol Biol. 2008 Mar;109(1-2):1-10. doi: 10.1016/j.jsbmb.2007.12.010. Epub 2007 Dec 8. J Steroid Biochem Mol Biol. 2008. PMID: 18243688 Review.

7

Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor alpha (ERalpha) in tissue microarrays of ERalpha positive human breast carcinomas.

Skliris GP, Rowan BG, Al-Dhaheri M, Williams C, Troup S, Begic S, Parisien M, Watson PH, Murphy LC. Skliris GP, et al. Among authors: watson ph. Breast Cancer Res Treat. 2009 Dec;118(3):443-53. doi: 10.1007/s10549-008-0267-z. Epub 2008 Dec 23. Breast Cancer Res Treat. 2009. PMID: 19104930 Free PMC article.

8

The relevance of phosphorylated forms of estrogen receptor in human breast cancer in vivo.

Murphy LC, Skliris GP, Rowan BG, Al-Dhaheri M, Williams C, Penner C, Troup S, Begic S, Parisien M, Watson PH. Murphy LC, et al. Among authors: watson ph. J Steroid Biochem Mol Biol. 2009 Mar;114(1-2):90-5. doi: 10.1016/j.jsbmb.2009.01.017. Epub 2009 Feb 6. J Steroid Biochem Mol Biol. 2009. PMID: 19429437 Review.

9

A phosphorylation code for oestrogen receptor-alpha predicts clinical outcome to endocrine therapy in breast cancer.

Skliris GP, Nugent ZJ, Rowan BG, Penner CR, Watson PH, Murphy LC. Skliris GP, et al. Among authors: watson ph. Endocr Relat Cancer. 2010 Jun 3;17(3):589-97. doi: 10.1677/ERC-10-0030. Print 2010 Sep. Endocr Relat Cancer. 2010. PMID: 20418363

10

Clinical significance of estrogen receptor phosphorylation.

Murphy LC, Seekallu SV, Watson PH. Murphy LC, et al. Among authors: watson ph. Endocr Relat Cancer. 2011 Jan 19;18(1):R1-14. doi: 10.1677/ERC-10-0070. Print 2011 Feb. Endocr Relat Cancer. 2011. PMID: 21149515 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

259 results

Search Page